ArticleBMC pediatrics2025
Abernethy malformation (Type II) presenting in a 6-day-old boy with Noonan syndrome: a case report.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAbernethy malformation (AM) is a rare vascular anomaly characterized by the diversion of splanchnic venous blood directly into the systemic circulation, bypassing the liver. We present the clinical features, diagnostic workup, and follow-up of a 6-day-old Chinese male with type II AM combined with Noonan syndrome (NS). CASE PRESENTATION: The patient was prenatally suspected of having AM based on ultrasonographic findings, which were postnatally confirmed through enhanced computed tomography (CT) and magnetic resonance (MR) imaging. Due to dysmorphic facial features, whole-exome sequencing (WES) was performed, identifying a heterozygous c.848G > A (p. Arg283Gln) variant in the LZTR1 gene (NM_006767.4), consistent with NS. During follow-up, the patient exhibited progressive elevation of liver enzymes and hyperammonemia, prompting laparoscopic portosystemic shunt ligation at six months of age. Postoperatively, the patient demonstrated rapid biochemical normalization and sustained clinical improvement.
conclusionsIn patients with RASopathies, clinicians should maintain a high index of suspicion for AM and NS. Comprehensive vascular evaluation, particularly imaging screening of the portal venous system, is essential to avoid missed diagnoses and ensure timely intervention, thereby improving patient outcomes. A multidisciplinary approach that integrates genetic testing, advanced imaging, and surgical expertise is essential for optimizing outcomes in these complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.